106 related articles for article (PubMed ID: 8822588)
1. Inhibitory effect of a synthetic prostacyclin analogue, beraprost, on urokinase-type plasminogen activator expression in RC-K8 human lymphoma cells.
Nomura N; Niiya K; Shinbo M; Ozawa T; Hayakawa Y; Higashiyama K; Fujimaki M; Sakuragawa N
Thromb Haemost; 1996 Jun; 75(6):928-32. PubMed ID: 8822588
[TBL] [Abstract][Full Text] [Related]
2. Modulation of urokinase-type plasminogen activator gene expression by inflammatory cytokines in human pre-B lymphoma cell line RC-K8.
Niiya K; Shinbo M; Ozawa T; Hayakawa Y; Sakuragawa N
Thromb Haemost; 1995 Dec; 74(6):1511-5. PubMed ID: 8772229
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid priming potentiates the induction of urokinase-type plasminogen activator by cyclic adenosine monophosphate in mouse mammary carcinoma cells.
Mira-y-Lopez R
J Cell Physiol; 1991 Apr; 147(1):46-54. PubMed ID: 1645361
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor enhances urokinase-type plasminogen activator gene expression in corneal epithelium.
Tao Y; Bazan HE; Bazan NG
Invest Ophthalmol Vis Sci; 1996 Sep; 37(10):2037-46. PubMed ID: 8814143
[TBL] [Abstract][Full Text] [Related]
5. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.
McGowen R; Biliran H; Sager R; Sheng S
Cancer Res; 2000 Sep; 60(17):4771-8. PubMed ID: 10987285
[TBL] [Abstract][Full Text] [Related]
6. Effects of a stable prostacyclin analogue beraprost sodium on VEGF and PAI-1 gene expression in vascular smooth muscle cells.
Atsuta H; Uchiyama T; Kanai H; Iso T; Tanaka T; Suga T; Maeno T; Arai M; Nagai R; Kurabayashi M
Int J Cardiol; 2009 Mar; 132(3):411-8. PubMed ID: 18471910
[TBL] [Abstract][Full Text] [Related]
7. Effects of N-(4-hydroxyphenyl) retinamide on urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in prostate adenocarcinoma cell lines.
Tanabe T
Hiroshima J Med Sci; 2000 Mar; 49(1):67-72. PubMed ID: 10824459
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 uses the protein kinase C/ interleukin-8/urokinase-type plasminogen activator pathway to increase the invasiveness of breast cancer cells.
Simeone AM; Nieves-Alicea R; McMurtry VC; Colella S; Krahe R; Tari AM
Int J Oncol; 2007 Apr; 30(4):785-92. PubMed ID: 17332916
[TBL] [Abstract][Full Text] [Related]
9. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.
Lee DH; Yang Y; Lee SJ; Kim KY; Koo TH; Shin SM; Song KS; Lee YH; Kim YJ; Lee JJ; Choi I; Lee JH
Cancer Res; 2003 Aug; 63(15):4648-55. PubMed ID: 12907645
[TBL] [Abstract][Full Text] [Related]
10. Regulation of urokinase plasminogen activator (uPA) activity by E-cadherin and hormones in mammary epithelial cells.
Sasaki CY; Lin H; Passaniti A
J Cell Physiol; 1999 Oct; 181(1):1-13. PubMed ID: 10457348
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional stimulation of the eNOS gene by the stable prostacyclin analogue beraprost is mediated through cAMP-responsive element in vascular endothelial cells: close link between PGI2 signal and NO pathways.
Niwano K; Arai M; Tomaru K; Uchiyama T; Ohyama Y; Kurabayashi M
Circ Res; 2003 Sep; 93(6):523-30. PubMed ID: 12919953
[TBL] [Abstract][Full Text] [Related]
12. IL-1 beta induces urokinase-plasminogen activator expression and cell migration through PKC alpha, JNK1/2, and NF-kappaB in A549 cells.
Cheng CY; Hsieh HL; Sun CC; Lin CC; Luo SF; Yang CM
J Cell Physiol; 2009 Apr; 219(1):183-93. PubMed ID: 19097143
[TBL] [Abstract][Full Text] [Related]
13. [Effect of cyclic AMP and phorbol ester on PAI-2 synthesis in a leukemic cell line PL-21 and on u-PA secretion in a pre-B cell lymphoma cell line RC-K8].
Niiya K; Sakuragawa N
Nihon Rinsho; 1992 Feb; 50(2):325-9. PubMed ID: 1319513
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor stimulates urokinase-type plasminogen activator expression in human gingival fibroblasts. Possible modulation by genistein and curcumin.
Smith PC; Santibañez JF; Morales JP; Martinez J
J Periodontal Res; 2004 Dec; 39(6):380-7. PubMed ID: 15491342
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase activity-dependent inhibition of urokinase-type plasminogen activator gene transcription by cyclic AMP in human pre-B lymphoma cell line RC-K8.
Shinbo M; Niiya K; al-Mokdad M; Hayakawa Y; Hiraga K; Fujimaki M; Sakuragawa N
Biochim Biophys Acta; 1995 Sep; 1268(3):293-9. PubMed ID: 7548228
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the uPA gene in various grades of human glioma cells.
Lakka SS; Bhattacharya A; Mohanam S; Boyd D; Rao JS
Int J Oncol; 2001 Jan; 18(1):71-9. PubMed ID: 11115541
[TBL] [Abstract][Full Text] [Related]
17. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of fibrinolytic activity of bovine aortic endothelial cells by ginsenoside Rb2.
Liu JW; Wei DZ; Du CB; Zhong JJ
Acta Pharmacol Sin; 2003 Feb; 24(2):102-8. PubMed ID: 12546716
[TBL] [Abstract][Full Text] [Related]
19. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
20. Negative regulation of urokinase-type plasminogen activator production through FGF-2-mediated activation of phosphoinositide 3-kinase.
Mochizuki Y; Tsuda S; Kanetake H; Kanda S
Oncogene; 2002 Oct; 21(46):7027-33. PubMed ID: 12370824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
